Physician profile
James Masterson
NPI 1639330889
$13,844.25
in general payments reported to CMS, 2019-2025
49 companies · $3,501 in 2025
The $3,501 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $989 · 2022: $4,296 · 2023: $2,733 · 2024: $2,325 · 2025: $3,501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,365 · Travel and Lodging: $957 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,364.55 |
| Travel and Lodging | $957.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $236.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $2,124.02 | 2021-2025 | Urolift, Solesta |
| Sumitomo Pharma America, INC. | $1,522.55 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $1,521.52 | 2021-2025 | Axonics, Spaceoar Vue System - 10ml, Rezum Generator |
| Bayer Healthcare Pharmaceuticals INC. | $886.19 | 2021-2025 | |
| Progenics Pharmaceuticals, INC. | $772.30 | 2022-2025 | Pylarify |
| Astellas Pharma US INC | $711.37 | 2021-2025 | Myrbetriq, Xtandi |
| Janssen Biotech, INC. | $694.84 | 2021-2025 | Erleada, Akeega |
| Urovant Sciences INC | $616.54 | 2021-2022 | |
| Abbvie INC. | $482.46 | 2021-2025 | |
| Antares Pharma, INC. | $418.80 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Endo Pharmaceuticals INC. | $366.78 | 2021-2024 | Xiaflex, Aveed, Edex |
| Pfizer INC. | $343.97 | 2021-2025 | |
| Halozyme INC | $338.96 | 2023 | |
| Coloplast Corp | $334.43 | 2021-2025 | Speedicath |
| Tolmar, INC. | $242.40 | 2023-2025 | Eligard, Jatenzo |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $233.25 | 2021-2025 | |
| Myovant Sciences INC. | $194.04 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $169.57 | 2021-2022 | |
| Endo USA, INC. | $163.78 | 2024-2025 | Xiaflex, Aveed |
| Immunitybio, INC. | $158.94 | 2024-2025 | |
| Mission Pharmacal Company | $142.78 | 2022-2023 | Uribel |
| Myriad Genetic Laboratories, INC. | $135.03 | 2021-2024 | Prolaris |
| Blue Earth Diagnostics | $133.54 | 2021-2025 | Posluma |
| Tempus Ai, INC | $127.41 | 2024 | Xt Cdx |
| Medtronic, INC. | $112.43 | 2023 | Interstim |
| Dendreon Pharmaceuticals LLC | $64.68 | 2021-2023 | Provenge |
| Ferring Pharmaceuticals INC. | $64.11 | 2024-2025 | Adstiladrin |
| Bioprotect Medical, INC. | $61.54 | 2025 | Bioprotect Balloon Implant System |
| Azurity Pharmaceuticals, INC. | $57.84 | 2025 | Azmiro |
| Axonics, INC. | $56.59 | 2021-2023 | Axonics |
| Novartis Pharmaceuticals Corporation | $52.71 | 2022-2025 | |
| Allergan, INC. | $49.26 | 2022 | |
| Caris Mpi, INC. | $49.15 | 2025 | Mi Cancer Seek |
| Olympus America INC. | $46.62 | 2023-2024 | Itind System |
| Accord Healthcare, INC. | $45.22 | 2025 | |
| Civco Medical Instruments | $43.58 | 2024-2025 | |
| Verity Pharmaceuticals INC. | $41.70 | 2025 | Tlando, Trelstar |
| Abc Home Medical Supply, INC. | $38.34 | 2022-2024 | |
| Vertex Pharmaceuticals Incorporated | $38.07 | 2025 | |
| Laborie Medical Technologies Corp. | $32.26 | 2025 | Endosheath Technology |
| Palette Life Sciences, INC. | $22.23 | 2022 | |
| Janssen Pharmaceuticals, INC | $22.00 | 2025 | Erleada |
| Alnylam Pharmaceuticals INC. | $19.89 | 2022 | |
| Avyxa Pharma, LLC | $18.92 | 2025 | |
| Valencia Technologies Corporation | $15.42 | 2025 | Ecoin Device Kit |
| Amgen INC. | $15.28 | 2023 | Prolia |
| Sun Pharmaceutical Industries INC. | $14.25 | 2024 | |
| Foundation Medicine, INC. | $13.66 | 2022 | |
| Millicent US INC | $13.03 | 2023 | Femring, Intrarosa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Masterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.